Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.40 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | PI4KA | P42356 | 1/20 | 0.39 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.39 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.39 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.39 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.37 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.36 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.36 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22084395 | 0.89 | ADORA2A (0.41) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL29375815 | 0.89 | ADORA2A (0.41) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL22085119 | 0.85 | PDE10A (0.42) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL22084385 | 0.83 | PDE10A (0.46) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL22085121 | 0.83 | PDE10A (0.46) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL22084387 | 0.83 | PDE10A (0.48) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL22084394 | 0.82 | ADORA2A (0.38) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL22084424 | 0.82 | PDE10A (0.38) | PDE10AHRH4ADORA2API4KAPI4K2B | |
| SCHEMBL22084423 | 0.80 | LPL (0.39) | PDE10AADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL22084396 | 0.80 | ADORA2A (0.41) | PDE10AHRH4ADORA2API4KAPI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020117938-A1 | PRODRUGS OF ANTI-CANCER AND ANTI-AUTOIMMUNE DISEASES THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2020-06-11 | — | — | WO | disclosed |